Scientists

Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.


Additional Resources

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.

 

Preclinical Imaging

The goal of the SNMMI Best Practices in Preclinical Imaging Initiative is to provide guidelines based on the community experience in designing and conducting preclinical imaging experiments.

Available Resources Include:

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Guidelines

The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

  • September 17, 2014Update on Kinevac Availability

    Bracco Diagnostics Inc. announced that production is moving forward with targeted efforts for Kinevac commercial availability by the end of September.
    (Government Relations News)

  • September 17, 2014Brain imaging pinpoints neurobiological basis for key symptoms associated with post-traumatic stress disorder

    First-order treatment of cancer typically involves chemo and/or radiation therapy and surgical intervention, but radionuclide therapies offer some advantages for select patients by delivering a very intense dose sequestered to affected tumor sites. These are the therapies currently available and in clinical trials, with a few novel compounds waiting for validation in the wings.
    (MI: Making a Difference)

  • September 17, 2014New non-invasive technique could revolutionize the imaging of metastatic cancer

    Bioluminescence, nanoparticles, gene manipulation – these sound like the ideas of a science fiction writer, but, in fact, they are components of an exciting new approach to imaging local and metastatic tumors. In preclinical animal models of metastatic prostate cancer, scientists at Virginia Commonwealth University Massey Cancer Center, VCU Institute of Molecular Medicine and Johns Hopkins Medical Institutions have provided proof-of-principle of a new molecular imaging approach that could revolutionize doctors' ability to see tumors that have metastasized to other sites in the body, including the bones.
    (MI: Making a Difference)

  • September 17, 2014FDG-PET/CT benefits breast cancer patients younger than 40

    While guidelines recommend FDG-PET/CT only as an optional workup for women with stage III breast cancer, the hybrid modality can help women younger than 40 who have potentially aggressive stage II breast cancer, according to a study published online September 11 in the Journal of Nuclear Medicine.
    (MI: Making a Difference)

Spotlight

Present Your Research

SNMMI offers a number of opportunities for nuclear medicine scientists and pharmacists to submit clinical and scientific abstracts to be considered for presentation at upcoming SNMMI conferences and meetings:

ACNM Annual and SNMMI 2015 Mid-Winter Meeting | January 22-25, 2015 in San Antonio, TX, USA
Abstract Submission Deadline: Thursday, December 4, 2014

AACR-SNMMI Joint Conference: State-of-the-Art: Molecular Imaging in Cancer Biology and Therapy | February 11-14, 2015 in San Diego, CA, USA
Abstract Submission Deadline: Friday, October 31, 2014

SNMMI 2015 Annual Meeting | June 6-10, 2015 in Baltimore, MD, USA
The call for abstracts for this event opens on Wednesday, October 15, 2014. Check back for additional information.

Featured Resources

  • Annual Reports

  • Journals

    Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.